GRFS

6.57

2.82% +0.18

Dopo l'orario di chiusura: 6.57

Grifols SA ADR (GRFS)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Perché GRFS Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$6.39

Aprire:

$6.59

Volume 24 ore:

1.51M

Capitalizzazione di mercato:

$4.46B

Reddito:

$7.21B

Utile/perdita netta:

$211.12M

Rapporto P/E:

22.78

EPS:

0.2884

Flusso di cassa netto:

$709.16M

1 W Prestazione:

+2.98%

1M Prestazione:

-4.64%

6M Prestazione:

-29.43%

1 anno Prestazione:

-8.88%

Intervallo 1D:

$6.54

$6.67

Portata 52W:

$5.3001

$12.15

Grifols SA ADR Stock (GRFS) Company Profile

Nome

Grifols SA ADR

Settore

Healthcare (1213)

Industria

Drug Manufacturers - General (18)

Telefono

34 93 571 05 00

Indirizzo

Avinguda de la Generalitat, 152-158, Parc de Negocis Can Sant Joan Sant Cugat del Vallès, Barcelona

Dipendente

20,000

Cinguettio

Prossima data di guadagno

2024-05-14

Ultimi documenti SEC

GRFS's Discussions on Twitter

Grifols SA ADR Stock (GRFS) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-04-12	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2023-03-03	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2023-02-16	Aggiornamento	Barclays	Underweight → Equal Weight
2023-01-18	Aggiornamento	Jefferies	Hold → Buy
2022-04-08	Iniziato	Morgan Stanley	Equal-Weight
2021-11-05	Downgrade	Deutsche Bank	Buy → Hold
2021-10-19	Downgrade	Barclays	Overweight → Underweight
2021-10-06	Aggiornamento	Citigroup	Neutral → Buy
2021-06-14	Aggiornamento	Deutsche Bank	Hold → Buy
2021-04-20	Iniziato	Deutsche Bank	Hold
2021-03-23	Aggiornamento	Credit Suisse	Neutral → Outperform
2021-03-11	Aggiornamento	HSBC Securities	Hold → Buy
2020-10-01	Aggiornamento	Citigroup	Sell → Neutral
2020-06-09	Downgrade	Citigroup	Neutral → Sell
2020-06-09	Aggiornamento	HSBC Securities	Reduce → Hold
2020-03-25	Downgrade	Citigroup	Buy → Neutral
2019-06-27	Aggiornamento	JP Morgan	Neutral → Overweight
2019-02-08	Downgrade	Berenberg	Buy → Hold
2018-10-11	Aggiornamento	Berenberg	Hold → Buy
2018-06-01	Iniziato	Barclays	Overweight
2017-10-31	Iniziato	Citigroup	Buy
2017-06-30	Downgrade	Goldman	Buy → Neutral
2017-04-06	Iniziato	BofA/Merrill	Buy
2017-01-03	Aggiornamento	JP Morgan	Neutral → Overweight
2016-02-09	Aggiornamento	Berenberg	Hold → Buy
2016-01-04	Downgrade	Morgan Stanley	Equal-Weight → Underweight
2015-12-02	Downgrade	HSBC Securities	Buy → Hold
2015-11-20	Downgrade	Berenberg	Buy → Hold
2015-04-28	Downgrade	Berenberg	Buy → Hold

Mostra tutto

Grifols SA ADR Borsa (GRFS) Ultime notizie

Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.

GlobeNewswire Inc.

CarMax Reports Downbeat Earnings, Joins Lovesac And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Benzinga

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

Zacks Investment Research

Procleix ArboPlex Assay® da Grifols recebe a marca CE, o primeiro e único NAT 4 em 1 para o rastreio de arbovírus

GlobeNewswire Inc.

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

Zacks Investment Research

Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Benzinga

Grifols SA ADR Azioni (GRFS) Dati Finanziari